Compared to mild disease, individuals with severe COVID-19 showed fewer CD56dimNK cells, whereas patients with severe COVID-19 who received dexamethasone displayed decreased abundance of cytotoxic, CD56dimNK, Th1, exhausted CD8+, and mast cell populations (Figures 1C, D). The gene discussed is CD8A; the disease is COVID-19.